2021-01-14
M&A in the pharmaceutical industry: the impact of target’s development of orphan drugs on acquisition premium and returns.
Publication
Publication
| Additional Metadata | |
|---|---|
| , , , , | |
| Ahmad, Farooq, Rajamani, Anjana | |
| hdl.handle.net/2105/56099 | |
| Finance & Investments | |
| Organisation | Rotterdam School of Management |
|
Ferrari, Chiara. (2021). M&A in the pharmaceutical industry: the impact of target’s development of orphan drugs on acquisition premium and returns. In Finance & Investments.http://hdl.handle.net/2105/56099 |
|